Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics

NCT00752960 is registered in ClinicalTrials.gov with Genomas, Inc as lead sponsor.

NCT NCT00752960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00752960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics
Lead sponsor
Genomas, Inc
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2007
Completion date
December 31, 2009
Enrollment
1,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

psychoses